Smithfield Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15
| Closed | -$3K | – | 1006 |
|
|
2023
Q3 | $3K | Hold |
15
| – | – | ﹤0.01% | 949 |
|
|
2023
Q2 | $3K | Hold |
15
| – | – | ﹤0.01% | 966 |
|
|
2023
Q1 | $3K | Hold |
15
| – | – | ﹤0.01% | 935 |
|
|
2022
Q4 | $3K | Hold |
15
| – | – | ﹤0.01% | 930 |
|
|
2022
Q3 | $3K | Hold |
15
| – | – | ﹤0.01% | 965 |
|
|
2022
Q2 | $2K | Hold |
15
| – | – | ﹤0.01% | 1031 |
|
|
2022
Q1 | $3K | Hold |
15
| – | – | ﹤0.01% | 1025 |
|
|
2021
Q4 | $3K | Hold |
15
| – | – | ﹤0.01% | 1026 |
|
|
2021
Q3 | $3K | Hold |
15
| – | – | ﹤0.01% | 1052 |
|
|
2021
Q2 | $3K | Hold |
15
| – | – | ﹤0.01% | 1023 |
|
|
2021
Q1 | $2K | Hold |
15
| – | – | ﹤0.01% | 1066 |
|
|
2020
Q4 | $2K | Hold |
15
| – | – | ﹤0.01% | 1053 |
|
|
2020
Q3 | $2K | Hold |
15
| – | – | ﹤0.01% | 1032 |
|
|
2020
Q2 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 953 |
|